Bausch Health Cos Cash on Hand 2012-2026 | BHC
Bausch Health Cos cash on hand from 2012 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
Bausch Health Cos Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $1,325 |
| 2024 | $1,201 |
| 2023 | $962 |
| 2022 | $591 |
| 2021 | $2,119 |
| 2020 | $1,816 |
| 2019 | $3,244 |
| 2018 | $723 |
| 2017 | $797 |
| 2016 | $542 |
| 2015 | $597 |
| 2014 | $323 |
| 2013 | $600 |
| 2012 | $916 |
| 2011 | $170 |
|
Bausch Health Cos Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2026-06-30 | $1,838 |
| 2026-03-31 | $1,312 |
| 2025-12-31 | $1,325 |
| 2025-09-30 | $1,340 |
| 2025-06-30 | $1,743 |
| 2025-03-31 | $1,157 |
| 2024-12-31 | $1,201 |
| 2024-09-30 | $750 |
| 2024-06-30 | $623 |
| 2024-03-31 | $755 |
| 2023-12-31 | $962 |
| 2023-09-30 | $780 |
| 2023-06-30 | $588 |
| 2023-03-31 | $531 |
| 2022-12-31 | $591 |
| 2022-09-30 | $497 |
| 2022-06-30 | $1,879 |
| 2022-03-31 | $2,460 |
| 2021-12-31 | $2,119 |
| 2021-09-30 | $1,904 |
| 2021-06-30 | $1,856 |
| 2021-03-31 | $1,893 |
| 2020-12-31 | $1,816 |
| 2020-09-30 | $1,988 |
| 2020-06-30 | $1,907 |
| 2020-03-31 | $1,923 |
| 2019-12-31 | $3,244 |
| 2019-09-30 | $827 |
| 2019-06-30 | $880 |
| 2019-03-31 | $784 |
| 2018-12-31 | $723 |
| 2018-09-30 | $973 |
| 2018-06-30 | $838 |
| 2018-03-31 | $909 |
| 2017-12-31 | $797 |
| 2017-09-30 | $1,892 |
| 2017-06-30 | $2,025 |
| 2017-03-31 | $1,210 |
| 2016-12-31 | $542 |
| 2016-09-30 | $659 |
| 2016-06-30 | $852 |
| 2016-03-31 | $1,310 |
| 2015-12-31 | $597 |
| 2015-09-30 | $1,420 |
| 2015-06-30 | $958 |
| 2015-03-31 | $12,219 |
| 2014-12-31 | $323 |
| 2014-09-30 | $809 |
| 2014-06-30 | $531 |
| 2014-03-31 | $576 |
| 2013-12-31 | $600 |
| 2013-09-30 | $596 |
| 2013-06-30 | $2,539 |
| 2013-03-31 | $414 |
| 2012-12-31 | $916 |
| 2012-09-30 | $258 |
| 2012-06-30 | $395 |
| 2012-03-31 | $332 |
| 2011-12-31 | $170 |
| 2011-09-30 | $258 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.129B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $44.899B | 17.67 |
| BridgeBio Pharma (BBIO) | United States | $13.352B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $9.749B | 24.85 |
| Aspen Pharmacare (APNHY) | South Africa | $4.248B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.409B | 20.18 |
| Personalis (PSNL) | United States | $1.687B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.652B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.019B | 9.58 |
| Assembly Biosciences (ASMB) | United States | $0.519B | 24.98 |
| Sol-Gel Technologies (SLGL) | Israel | $0.178B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.043B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |